Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nutrition ; 118: 112259, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38016253

RESUMEN

OBJECTIVES: This study investigated the effects of regular nutrition consultations on reducing risk factors, including body mass index, body composition, blood pressure, blood lipid profile, blood glucose-related markers, and inflammatory factors for cardiovascular diseases. METHODS: Data were collected from participants (n = 129) who completed eight dietary consultations and were divided into two groups according to the regularity of the consultations: an irregular group (with irregular consultation intervals; n = 39) and a regular group (accepted consultation once every 3 wk; n = 90). RESULTS: Compared with the irregular group, the regular group had more significant reductions in cardiovascular disease risk factors, such as body mass index, body fat, triglycerides, total cholesterol, low-density lipoprotein cholesterol, and insulin levels. Moreover, participants with a body mass index ≥ 27 kg/m2 presented significantly obvious improvements in cardiovascular risk factors, such as body weight; body mass index; visceral fat weight; and triglyceride, total cholesterol, low-density lipoprotein cholesterol, glycated hemoglobin, and insulin levels. CONCLUSION: There is a proven benefit to regular nutrition consultation for adults with risk factors of cardiovascular diseases, particularly those who are obese.


Asunto(s)
Enfermedades Cardiovasculares , Insulinas , Adulto , Humanos , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/prevención & control , Factores de Riesgo , Glucemia , Triglicéridos , Índice de Masa Corporal , LDL-Colesterol , Derivación y Consulta
2.
Nutrients ; 15(19)2023 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-37836574

RESUMEN

The purpose of this study was to compare the effects of nutritional supplement drinks (NSDs) and nutritional education (NE) on the nutritional status and physical performance of older nursing home residents who were at risk of malnutrition. This study was a clustered, randomized, parallel, multi-center clinical trial, with 107 participants more than 65 years old and at risk of malnutrition recruited from several nursing homes in this study. Participants were divided into two groups: an NE group (n = 50) and an NSD group (n = 57). The NE group was given NE by a dietitian, while the NSD group was provided with two packs of NSD except receiving NE (Mei Balance, Meiji Holdings, Tokyo, Japan) per day as a snack between meals and before bed. Anthropometric data, blood pressure, nutritional status, blood biochemical biomarkers, and physical performance were measured before and after 12-week interventions. After 12 weeks of NE combined with NSD intervention, body weight, body-mass index, the mini nutritional assessment-short form (MNA-SF) score, walking speed, and SF-36 questionnaire score were improved in older nursing home residents at risk of malnutrition.


Asunto(s)
Desnutrición , Estado Nutricional , Humanos , Anciano , Evaluación Nutricional , Desnutrición/prevención & control , Casas de Salud , Rendimiento Físico Funcional , Evaluación Geriátrica
3.
Curr Res Food Sci ; 7: 100546, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37483276

RESUMEN

Caulerpa lentillifera (CL), also called sea grape, is a type of edible green alga which was reported to have antioxidative and immunomodulatory potential. This study aimed to investigate the hepatoprotective effects of CL in a rat model of chronic ethanol exposure. Wistar rats were assigned to four groups and supplied with an isocaloric control liquid diet (group C), an ethanol liquid diet (group E), a control liquid diet supplemented with 5% CL (group CC), or an ethanol liquid diet supplemented with 5% CL (group EC) for a 12-week experimental period. Ethanol feeding induced steatosis, inflammation, and changes in the gut microbiota by the end of the study, whereas CL supplementation significantly improved liver injuries and decreased circulatory endotoxin levels. Moreover, we also found that CL reversed ethanol-induced elevation of hepatic toll-like receptor 4 (TLR4), MyD88 protein expression, the phosphorylated-nuclear factor (NF)-κB-to-NF-κB ratio, and proinflammatory cytokine concentrations. Additionally, CL also increased the abundance of Akkermansia and tight junction proteins and diminished the Firmicutes-to-Bacteroidetes ratio. Dietary CL inhibited the progression of alcoholic liver disease, and some of the possible mechanisms may be strengthening the intestinal barrier function, alleviating dysbiosis, and modulating the TLR4 pathway.

4.
Bioengineering (Basel) ; 9(10)2022 Oct 06.
Artículo en Inglés | MEDLINE | ID: mdl-36290494

RESUMEN

The purpose of this study was to clarify the role of saturated fats from cocoa butter (plant source) compared with lard (animal source) on alcoholic liver damage in rats. Male Wistar rats were fed either a control diet (C) or an ethanol diet (E), and the dietary fats (corn oil, olive oil, and safflower oil) of these two diets were further replaced by lard (CL, EL) or cocoa butter (CC, EC). After 8-week feeding, plasma aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities, hepatic triglyceride (TG) levels, plasma intercellular adhesion molecular (ICAM)-1 levels, hepatic cytochrome P450 2E1 (CYP2E1) protein expression, and hepatic interleukin (IL)-1ß significantly increased in the E group compared to the C group. In addition, hepatic histopathological scores of fatty changes, inflammatory cell infiltration, and degeneration and necrosis in the E group were significantly higher compared to those in the C group. However, fatty changes were significantly inhibited only in the EC group as well as hepatic inflammatory cell infiltration, degeneration, and necrosis being significantly lower in the EL and EC groups. Plasma ICAM-1 and hepatic tumor necrosis factor (TNF)-α, IL-1ß, IL-6, and IL-10 levels were significantly lower in the EL and EC groups than those in the E group. Moreover, a correlation analysis showed that hepatic histopathological scores of degeneration and necrosis were significantly positively correlated with erythrocytic oleic acid (C18:1) and were negatively correlated with linoleic acid (C18:2). In conclusion, cocoa butter protected the liver against lipid accumulation and inflammation in rats chronically fed ethanol.

5.
Foods ; 10(11)2021 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-34828861

RESUMEN

Background and aims: Sarcopenia is recognized as a major public health issue, because it is prevalent in the elderly, especially those who live in long-term care facilities. The purpose of this study was to investigate the beneficial effects of milk or soy milk combined with resistance exercise on the muscle mass and muscle strength of individual elderly nursing home residents with sarcopenia. Methods: This study was a randomized controlled trial (clincaltrials.gov as NCT05035121) that recruited very old (>75 years) subjects with sarcopenia in a nursing home (Su-Ao and Yuanshan Branches, Taipei Veterans General Hospital) from June to December 2017. Thirty-five elderly (84.9 ± 6.1 years old) subjects were recruited and divided into three groups: control (n = 12), milk supplemented (n = 12), and soy milk supplemented (n = 11). All participants joined a mild resistance exercise training program three times a week (30 min/time). Moreover, elderly subjects in the milk and soy milk groups drank 200 mL of milk or soy milk for breakfast and as a snack after exercise. Results: After 12 weeks, compared to the baseline, calf circumferences had significantly increased in the control and soy milk groups (p = 0.0362 and p = 0.0197, respectively). Hand grip strength had significantly improved in the milk and soy milk groups (p = 0.0407 and p = 0.0096, respectively). In addition, there was no difference among the three groups. Conclusions: Mild resistance exercise combined with milk or soy milk improved the calf circumference and hand grip strength in very old nursing home residents with sarcopenia.

6.
Nutrients ; 12(2)2020 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-32054079

RESUMEN

The purpose of this study was to investigate whether or not Coriandrum sativum seed extract (CSSE) can ameliorate memory impairment in senescence-accelerated mouse-prone 8 (SAMP8) mice. Sixteen 10-week-old male SAMP8 mice were divided into two groups, which were orally administrated water (SAMP8(-)) or CSSE (200 mg/kg/day; SAMP8(+)). Eight 10-week-old male Institute of Cancer Research (ICR) mice were used as a normal control group and were also orally administrated water. The mean escape time in the Barnes maze test of SAMP8(-) mice was significantly longer than that of ICR mice. However, SAMP8(+) mice showed a shorter mean escape time compared to that of SAMP8(-) mice. Neurofilament messenger (m)RNA levels significantly decreased in the frontal lobe of SAMP8(-) mice when compared with ICR mice, but significantly increased in SAMP8(+) mice relative to SAMP8(-) mice. In addition, mRNA levels of inducible nitric oxide synthase (iNOS) and neuronal (n)NOS significantly increased in the frontal lobe of SAMP8(-) mice, but only the mRNA level of nNOS significantly decreased in SAMP8(+) mice. These results indicated that continuous oral administration of CSSE for 12 weeks could ameliorate aging-induced memory declines in the senescence-accelerated SAMP8 mouse model.


Asunto(s)
Coriandrum/química , Trastornos de la Memoria/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/administración & dosificación , Extractos Vegetales/aislamiento & purificación , Semillas/química , Administración Oral , Animales , Modelos Animales de Enfermedad , Lóbulo Frontal/metabolismo , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/metabolismo , Trastornos de la Memoria/psicología , Ratones Endogámicos ICR , Ratones Transgénicos , Óxido Nítrico Sintasa de Tipo II/metabolismo , ARN Mensajero/metabolismo , Factores de Tiempo
7.
J Food Sci ; 84(9): 2682-2687, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31441509

RESUMEN

An imbalance of energy intake and expenditure leads to fat accumulation and metabolic disorders. The aim of the study was to investigate the effects of antroquinonol on diet-induced obesity. Thirty-two rats were divided into a control group (C), an obesogenic group (OB), and two experimental groups consuming 25 (OB-AQ25) and 50 mg/kg (OB-AQ50) antroquinonol (n = 8). After a 12-week experimental period, we collected blood, liver, abdominal fat, and gastrocnemius muscle tissue for analysis. The obesogenic diet induced greater weight gain and fat accumulation, and increased hepatic lipids, and tumor necrosis factor-α and interleukin-1ß concentrations in rats. Antroquinonol consumption reduced epididymal and hepatic lipids and inflammatory cytokines. We found that antroquinonol upregulated hepatic adenosine monophosphate-activated protein kinase and downregulated sterol regulatory element-binding protein-1 protein expressions and downregulated fatty acid synthase mRNA expression. In addition, gastrocnemius fibronectin type III domain containing 5 protein expression was also higher in the B group. In conclusion, our results suggested that consuming antroquinonol may ameliorate diet-induced abdominal and hepatic fat accumulation. PRACTICAL APPLICATION: Antroquinonol is a bioactive compound derived from Antrodia camphorate which is traditionally used in Chinese medicinal cuisine, and is used for developing functional foods in Taiwan. This is the first study investigating the possible effects of antroquinonol on obesity and we found that antroquinonol can ameliorate diet-induced obesity, and therefore may be used in further studies and functional food development.


Asunto(s)
Dieta Alta en Grasa , Grasa Intraabdominal/efectos de los fármacos , Hígado , Ubiquinona/análogos & derivados , Animales , Hígado/efectos de los fármacos , Hígado/metabolismo , Ratas , Ubiquinona/farmacología
8.
Appl Physiol Nutr Metab ; 44(3): 320-325, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30189154

RESUMEN

The objective of this study was to evaluate the effects of the hot-water extract of defatted Camellia oleifera seeds (CSE) on body and liver fat accumulation in rats. Forty rats were divided into 5 groups and each group was fed either an isocaloric control diet or a high-fat liquid diet with 0% (H), 0.12% (H1), 0.24% (H2), or 0.48% CSE (H3) for 8 weeks. Ingestion of the high-fat liquid diet increased abdominal and liver fat accumulation, although no difference was found in body weights compared with rats fed the control diet. We found that rats fed the H2 and H3 diets had lower plasma alanine aminotransferase activities than the H group in the fourth and eighth weeks. At the end of the study, the H2 and H3 groups also had lower epididymal and retroperitoneal fat masses, and all CSE groups had lower circulatory leptin levels than the H group. CSE consumption decreased hepatic fat accumulation in terms of liver triglycerides and a histopathology analysis, and ameliorated high-fat diet-induced elevation of hepatic tumor necrosis factor-α levels. We also found that CSE groups had lower malondialdehyde and hydroxyproline levels in the liver. Our results suggested that CSE may exert beneficial effects through decreasing body fat accumulation and hepatic steatosis and regulating adipokine levels in diet-induced nonalcoholic fatty liver disease.


Asunto(s)
Camellia/química , Grasa Intraabdominal/metabolismo , Hígado/metabolismo , Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico , Extractos Vegetales/farmacología , Alanina Transaminasa/sangre , Animales , Peso Corporal , Dieta Alta en Grasa , Hidroxiprolina/análisis , Leptina/sangre , Hígado/efectos de los fármacos , Malondialdehído/análisis , Enfermedad del Hígado Graso no Alcohólico/patología , Ratas , Ratas Wistar , Semillas/química , Taiwán , Triglicéridos/análisis , Factor de Necrosis Tumoral alfa
9.
Nutrients ; 10(10)2018 Oct 17.
Artículo en Inglés | MEDLINE | ID: mdl-30336562

RESUMEN

Endothelial dysfunction leads to elevation of blood pressure and vascular remodeling, which may result in tissue injuries. The aim of this study was to investigate the mechanisms and effects of antroquinonol on hypertension and related renal injuries. Rats were fed water containing 25 mg/kg/day Nω-nitro-l-arginine methyl ester (L-NAME) to induce hypertension, and a diet with or without antroquinonol (20 or 40 mg/kg/day) for a 9-week experiment. During the experimental period, antroquinonol reduced the elevation of systolic and diastolic blood pressure. At the end of the study, we found that the antroquinonol groups had lower serum creatinine, renal endothelin-1, angiotensin II, and malondialdehyde levels and arteriole thickening. We found that the 40 mg/kg/day antroquinonol group had lower renal nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activities, greater nuclear factor erythroid-2, and heme oxygenase-1 expressions. Moreover, we also found that antroquinonol decreased proinflammatory cytokine concentrations in the kidney by modulating the nuclear factor-κB pathway. These results suggest that antroquinonol may ameliorate hypertension and improve renal function by reducing oxidative stress and inflammation in rats with endothelial dysfunction.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Antrodia/química , Productos Biológicos/uso terapéutico , Hipertensión/tratamiento farmacológico , Riñón/efectos de los fármacos , Ubiquinona/análogos & derivados , Animales , Antiinflamatorios/uso terapéutico , Antihipertensivos/farmacología , Antihipertensivos/uso terapéutico , Antioxidantes/uso terapéutico , Arginina/análogos & derivados , Arteriolas/efectos de los fármacos , Arteriolas/patología , Productos Biológicos/farmacología , Biomarcadores/metabolismo , Presión Sanguínea/efectos de los fármacos , Modelos Animales de Enfermedad , Hipertensión/metabolismo , Hipertensión/patología , Hipertensión/fisiopatología , Inflamación/metabolismo , Inflamación/prevención & control , Riñón/metabolismo , Enfermedades Renales/etiología , Enfermedades Renales/metabolismo , Enfermedades Renales/patología , Enfermedades Renales/prevención & control , Masculino , Malondialdehído/sangre , NG-Nitroarginina Metil Éster , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar , Ubiquinona/farmacología , Ubiquinona/uso terapéutico
10.
Nutrients ; 9(8)2017 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-28777296

RESUMEN

Dysregulated iron metabolism is associated with altered body composition and nonalcoholic fatty liver disease (NAFLD); however, mechanisms underlying this association remain undefined. We investigated this association in 117 women. Middle-aged women (≥45 years old (y)) were heavier and had lower serum iron, higher serum hepcidin, ferritin, and severe NAFLD incidence than young adult women (<45 y). Age-adjusted linear regression analysis revealed that young adult women with the highest serum iron:ferritin ratio (Tertile 3) had a 5.08-unit increased percentage of muscle mass [ß = 5.08 (1.48-8.68), p < 0.001] and a 1.21-unit decreased percentage visceral fat mass [ß = -1.21 (-2.03 to -0.39), p < 0.001] compared with those with the lowest serum iron:ferritin ratio (Tertile 1; reference). The iron:ferritin dietary pattern, characterized by high consumption of beef, lamb, dairy products, fruits, and whole grains, and low consumption of refined carbohydrates (rice, noodles, and bread and pastries), and deep- and stir-fried foods, predicted a 90% [odds ratio: 0.10, 95% confidence interval: 0.02-0.47, p < 0.001] reduced risk of mild vs. moderate and severe NAFLD in young adult women. Our findings suggest that the serum iron:ferritin ratio more accurately predicts body composition and reduced risk of severe fatty liver progression in young adult women compared to middle-aged women.


Asunto(s)
Composición Corporal , Ferritinas/sangre , Hierro/sangre , Enfermedad del Hígado Graso no Alcohólico/sangre , Adulto , Factores de Edad , Biomarcadores/sangre , Estudios de Casos y Controles , Estudios Transversales , Dieta Saludable , Conducta Alimentaria , Femenino , Estado de Salud , Humanos , Incidencia , Modelos Lineales , Persona de Mediana Edad , Análisis Multivariante , Enfermedad del Hígado Graso no Alcohólico/diagnóstico , Enfermedad del Hígado Graso no Alcohólico/epidemiología , Enfermedad del Hígado Graso no Alcohólico/fisiopatología , Oportunidad Relativa , Factores de Riesgo , Índice de Severidad de la Enfermedad , Factores Sexuales , Taiwán/epidemiología
11.
J Nutr Biochem ; 39: 68-76, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27816762

RESUMEN

The accumulation of advanced glycation end-products (AGEs) and the enhanced interaction of AGE with their cellular receptor (RAGE) have been implicated in the progression of chronic kidney disease. The purpose of this study was to examine whether the AGE/RAGE-induced nephrotoxic effects are associated with inflammasome activation and endothelial dysfunction. Chronic renal injury was examined in BALB/c mice by the long-term administration of carbonyl-AGE for 16 weeks. Endothelial dysfunction was detected by measuring the number of circulating endothelial progenitor cells (EPCs) and the levels of nitric oxide synthase (eNOS) and nitric oxide (NO) in kidneys. Results showed that administration of methylglyoxal-bovine serum albumin (MG-BSA) AGE accelerated renal MG, carboxyethyl lysine, carboxymethyl lysine and malondialdehyde formation and, in parallel, the levels of serum creatinine and blood urea nitrogen (BUN) were significantly increased. Expression of RAGE and NLRP3 inflammasome-related proteins (TXNIP, NLRP3, procaspase-1 and caspase-1) and IL (interleukin)-1ß secretion were upregulated, whereas the levels of EPCs, eNOS and NO were lower in MG-BSA-treated mice. This induction by MG-BSA was significantly inhibited by RAGE antagonist. Our results firstly reveal a possible mechanism of AGE-mediated renal dysfunction upon NLRP3 inflammasome activation. Therapeutic blockade of RAGE may ameliorate renal and endothelial functions in subjects under high AGE burden.


Asunto(s)
Productos Finales de Glicación Avanzada/farmacología , Inflamasomas/genética , Enfermedades Renales/genética , Riñón/efectos de los fármacos , Proteína con Dominio Pirina 3 de la Familia NLR/genética , Animales , Nitrógeno de la Urea Sanguínea , Creatinina/sangre , Citocinas/sangre , Células Progenitoras Endoteliales/efectos de los fármacos , Células Progenitoras Endoteliales/metabolismo , Inflamasomas/metabolismo , Riñón/metabolismo , Enfermedades Renales/tratamiento farmacológico , Enfermedades Renales/etiología , Ratones , Ratones Endogámicos BALB C , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo III/genética , Óxido Nítrico Sintasa de Tipo III/metabolismo , Estrés Oxidativo/efectos de los fármacos , Piruvaldehído/farmacología , Especies Reactivas de Oxígeno/metabolismo , Receptor para Productos Finales de Glicación Avanzada/genética , Receptor para Productos Finales de Glicación Avanzada/metabolismo , Albúmina Sérica Bovina/farmacología
12.
Gastroenterol Res Pract ; 2016: 4694726, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27143963

RESUMEN

The aim of this study was to investigate the ameliorative effects of fish oil on hepatic injury in ethanol-fed rats based on the intestinal permeability and microbiota. Rats were assigned to 6 groups and fed either a control diet or an ethanol diet such as C (control), CF25 (control with 25% fish oil), CF57 (control with 57% fish oil), E (ethanol), EF25 (ethanol with 25% fish oil), and EF57 (ethanol with 57% fish oil) groups. Rats were sacrificed at the end of 8 weeks. Plasma aspartate aminotransferase (AST) and aminotransferase (ALT) activities, hepatic cytokines, and plasma endotoxin levels were significantly higher in the E group. In addition, hepatic histopathological analysis scores in the E group were significantly elevated. Rats in the E group also showed increased intestinal permeability and decreased numbers of fecal Bifidobacterium. However, plasma AST and ALT activities and hepatic cytokine levels were significantly lower in the EF25 and EF57 groups. Histological changes and intestinal permeability were also improved in the EF25 and EF57 groups. The fecal Escherichia coli numbers were significantly lower, but fecal Bifidobacterium numbers were significantly higher in the EF25 and EF57 groups.

13.
Food Funct ; 6(5): 1692-700, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25910227

RESUMEN

Clinical and animal experiments indicated that gut-derived endotoxin and imbalanced intestinal microbiota contribute to the pathogenesis of alcoholic liver disease (ALD). In this study, we investigated whether synbiotic supplementation could improve ALD in rats by altering the intestinal microbial composition and improving the intestinal integrity. Male Wistar rats were divided into four groups according to plasma aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities and subjected to either a normal liquid diet (C), a normal liquid diet with synbiotic supplementation (C + S), an ethanol liquid diet (E), or an ethanol liquid diet with synbiotic supplementation (E + S) for 12 weeks. Results revealed that the ethanol-fed group showed increases in plasma AST and ALT activities, the endotoxin level, the hepatic triglyceride (TG) level, and hepatic tumor necrosis factor (TNF)-α, interleukin (IL)-1ß and IL-6 levels, and a decrease in the hepatic IL-10 level. Ethanol-feeding also contributed to increased intestinal permeability and decreased fecal bifidobacteria and lactobacilli amounts. However, synbiotic supplementation effectively attenuated the plasma endotoxin, hepatic TG and TNF-α levels, and increased the hepatic IL-10 level. Furthermore, synbiotic supplementation protected the rats against ethanol-induced hyperpermeability of the intestine, and significantly increased amounts of bifidobacteria and lactobacilli in the feces. This study demonstrated that synbiotics possess a novel hepatoprotective function by improving the intestinal permeability and microbiota in rats with ethanol-induced liver injury.


Asunto(s)
Etanol/efectos adversos , Intestinos/microbiología , Hepatopatías Alcohólicas/tratamiento farmacológico , Microbiota/efectos de los fármacos , Simbióticos/administración & dosificación , Animales , Bifidobacterium/crecimiento & desarrollo , Endotoxinas/metabolismo , Humanos , Interleucina-1beta/genética , Interleucina-1beta/inmunología , Interleucina-6/genética , Interleucina-6/inmunología , Mucosa Intestinal/metabolismo , Intestinos/inmunología , Lactobacillus/crecimiento & desarrollo , Hepatopatías Alcohólicas/genética , Hepatopatías Alcohólicas/inmunología , Hepatopatías Alcohólicas/microbiología , Masculino , Ratas , Ratas Wistar , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología
14.
Food Funct ; 5(11): 2898-904, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25205218

RESUMEN

Soy protein was known to have renal-protective effects. The aim of this study was to investigate the effects of different doses of soybean ß-conglycinin, one of the main storage proteins in soy, on diabetic nephropathy in the rat. We used 40 Wistar rats with eight rats in each group. Diabetes mellitus was induced in rats by an intravenous injection of streptozotocin. The groups included a control group (Ctrl) fed with the standard AIN93-M diet, while other groups were fed with AIN-93M with the addition of NaCl to induce diabetic nephropathy (DN). DN rats were divided into the DN control (DN) group, the soy protein (DN + SP) group, the low-dose ß-conglycinin (DN + B) group, and the high-dose ß-conglycinin (DN + 2B) group. After a 27 weeks experimental period, we found that soy protein and ß-conglycinin decreased blood glucose via increasing the insulin sensitivity, with an enhanced cholesterol-lowering effect of ß-conglycinin-mediated hepatic LDL receptor protein expression. Otherwise, there were beneficial effects of soy protein and ß-conglycinin on renal function markers. Through the inhibition of angiotensin-converting enzyme (ACE), soy protein and ß-conglycinin retarded the progression of diabetic nephropathy by decreasing the blood pressure and histological changes. In conclusion, soy protein and ß-conglycinin may retard the progression of diabetic nephropathy by increasing insulin sensitivity, regulating lipid metabolism, improving renal function markers, and inhibiting ACE activity.


Asunto(s)
Antígenos de Plantas/farmacología , Nefropatías Diabéticas/tratamiento farmacológico , Globulinas/farmacología , Resistencia a la Insulina , Riñón/efectos de los fármacos , Peptidil-Dipeptidasa A/metabolismo , Proteínas de Almacenamiento de Semillas/farmacología , Cloruro de Sodio Dietético/administración & dosificación , Proteínas de Soja/farmacología , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Animales , Glucemia/metabolismo , Creatina/sangre , Creatina/orina , Relación Dosis-Respuesta a Droga , Riñón/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , PPAR gamma/metabolismo , Ratas , Ratas Wistar , Receptores de Lipoproteína/metabolismo , Albúmina Sérica/metabolismo , Cloruro de Sodio Dietético/efectos adversos , Factor de Necrosis Tumoral alfa/metabolismo , Regulación hacia Arriba
15.
ACS Nano ; 8(3): 2704-13, 2014 Mar 25.
Artículo en Inglés | MEDLINE | ID: mdl-24533852

RESUMEN

The properties of confined liquid water, or liquid water in contact with hydrophobic surfaces, are significantly different from those of bulk liquid water. However, all of water's commonly described properties are related to inert "bulk liquid water" which comprises a tetrahedral hydrogen-bonded network. In this work, we report an innovative and facile method for preparing small water clusters (SWCs) with reduced affinity hydrogen bonds by letting bulk water flow through supported Au nanoparticles (NPs) under resonant illumination to give NP-treated (AuNT) water at constant temperature. Utilizing localized surface plasmon resonance on illuminated Au NPs, the strong hydrogen bonds of bulk water can be disordered when water is located at the illuminated Au/water interface. The prepared SWCs are free of Au NPs. The energy efficiency for creating SWCs is ∼17%. The resulting stable AuNT water exhibits distinct properties at room temperature, which are significantly different from the properties of untreated bulk water, examples being their ability to scavenge free hydroxyl and 2,2-diphenyl-1-picrylhydrazyl radicals and to effectively reduce NO release from lipopolysaccharide-induced inflammatory cells.

16.
Br J Nutr ; 111(1): 78-85, 2014 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-23803175

RESUMEN

The objective of the present study was to investigate the effects of ß-conglycinin and soya isoflavones on diabetic nephropathy (DN). DN was induced by an intravenous injection of streptozotocin (25 mg/kg) in spontaneously hypertensive rats. DN rats were divided into a non-diabetic group (C, control group) and three DN groups (D, DN with control diet; B, DN+control diet with one-eighth of casein replaced by ß-conglycinin as the protein source; and I, DN+control diet with 0·01 % soya isoflavones). After a 4-week experimental period, we found that fasting blood sugar and plasma and kidney advanced glycation end product levels and 24 h urinary protein excretion of the B group were significantly lower than those of the D group and insulin sensitivity and nephrin expression of the B group were significantly higher than those of the D group. In addition, systolic blood pressure, angiotensin-converting enzyme activity, angiotensin II level and plasma TAG level of the B group were significantly lower than those of the D group, whereas only the levels of plasma TAG and thiobarbituric acid-reactive substances of the I group were lower than those of the D group. In conclusion, ß-conglycinin may be beneficial for retarding DN progression and this effect cannot be completely explained by its isoflavone content.


Asunto(s)
Antígenos de Plantas/uso terapéutico , Nefropatías Diabéticas/dietoterapia , Proteínas en la Dieta/uso terapéutico , Globulinas/uso terapéutico , Glycine max/química , Isoflavonas/farmacología , Riñón/efectos de los fármacos , Proteínas de la Membrana/metabolismo , Proteínas de Almacenamiento de Semillas/uso terapéutico , Proteínas de Soja/uso terapéutico , Angiotensina II/sangre , Animales , Antígenos de Plantas/farmacología , Glucemia/metabolismo , Presión Sanguínea/efectos de los fármacos , Diabetes Mellitus Experimental/complicaciones , Diabetes Mellitus Experimental/dietoterapia , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/fisiopatología , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/dietoterapia , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/fisiopatología , Nefropatías Diabéticas/metabolismo , Nefropatías Diabéticas/fisiopatología , Proteínas en la Dieta/farmacología , Globulinas/farmacología , Productos Finales de Glicación Avanzada/metabolismo , Resistencia a la Insulina , Riñón/metabolismo , Riñón/fisiopatología , Masculino , Peptidil-Dipeptidasa A/metabolismo , Fitoterapia , Preparaciones de Plantas/farmacología , Preparaciones de Plantas/uso terapéutico , Ratas , Ratas Endogámicas SHR , Proteínas de Almacenamiento de Semillas/farmacología , Proteínas de Soja/farmacología , Sustancias Reactivas al Ácido Tiobarbitúrico , Triglicéridos/sangre
17.
J Nutr Biochem ; 23(6): 679-84, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21813270

RESUMEN

OBJECTIVE: This investigation attempted to clarify the effects of soy protein on alcoholic liver disease (ALD) in rats undergoing ethanol withdrawal. METHODS: Alcoholic liver disease was induced in rats by administration of a low-carbohydrate ethanol liquid diet for 12 weeks, after which the ethanol was withdrawn and the rats were divided into two experimental groups: a control group (EC group) and a soy protein group (EP group) for 4 weeks. RESULTS: After the 12-week ALD-inducing period, the ethanol group had significantly higher hepatic lipid accumulation, oxidative stress and inflammation. We found that the EP group had significantly lower hepatic lipids, malondialdehyde, tumor necrosis factor-α, interleukin (IL)-1ß, IL-6, hydroxyproline levels and myeloperoxidase activity compared to the EC group. Moreover, the fecal total cholesterol and total lipids were higher in the EP group. Expression of the hepatic cytochrome P450 2E1 (CYP2E1) protein in the EP group was significantly lower than that in the EC group, and the hepatic peroxisome proliferator-activated receptor (PPAR) α and cytochrome P450 4A (CYP4A) protein expressions in the EP group were significantly higher than those in the EC group. In the histopathological analysis, we also found that soy protein ameliorated fat accumulation in the liver. CONCLUSION: These results suggest that soy protein may improve alcohol-induced lipid accumulation, oxidative stress and inflammation by decreasing proinflammatory cytokines and CYP2E1 protein expression and by increasing PPARα and CYP4A protein expressions and fecal lipid excretion, thereby producing beneficial effects on ALD during ethanol withdrawal.


Asunto(s)
Etanol/toxicidad , Hepatopatías Alcohólicas/tratamiento farmacológico , Hígado/efectos de los fármacos , Proteínas de Soja/farmacología , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico , Animales , Colesterol/sangre , Citocromo P-450 CYP2E1/genética , Citocromo P-450 CYP2E1/metabolismo , Citocromo P-450 CYP4A/genética , Citocromo P-450 CYP4A/metabolismo , Etanol/administración & dosificación , Interleucina-6/metabolismo , Hígado/metabolismo , Hígado/patología , Hepatopatías Alcohólicas/fisiopatología , Masculino , Malondialdehído/metabolismo , Estrés Oxidativo/efectos de los fármacos , PPAR alfa/genética , PPAR alfa/metabolismo , Ratas , Ratas Wistar , Síndrome de Abstinencia a Sustancias/fisiopatología , Triglicéridos/sangre , Factor de Necrosis Tumoral alfa/metabolismo
18.
Br J Nutr ; 107(5): 749-54, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22032343

RESUMEN

Green tea catechin has been proposed to have an anti-obesity effect. The aim of the present study was to investigate whether the effect of catechin-rich green tea in combination with inulin affects body weight and fat mass in obese and overweight adults. A total of thirty subjects were divided into a control group and an experimental group who received 650 ml tea or catechin-rich green tea plus inulin. A reduction of body weight ( - 1·29 (sem 0·35) kg) and fat mass (0·82 (sem 0·27) kg) in the experimental group was found after 6 weeks, and no adverse effects were observed. After refraining from consumption for 2 weeks, sustained effects on body weight and fat mass were observed. We conclude that continuous intake of catechin-rich green tea in combination with inulin for at least 3 weeks may be beneficial for weight management.


Asunto(s)
Fármacos Antiobesidad/uso terapéutico , Catequina/uso terapéutico , Alimentos Formulados , Inulina/uso terapéutico , Sobrepeso/dietoterapia , Té/química , Adiposidad , Adulto , Fármacos Antiobesidad/efectos adversos , Fármacos Antiobesidad/química , Composición Corporal , Índice de Masa Corporal , Catequina/efectos adversos , Catequina/análisis , Femenino , Alimentos Formulados/análisis , Humanos , Hipertensión/etiología , Hipertensión/prevención & control , Inulina/efectos adversos , Masculino , Persona de Mediana Edad , Obesidad/dietoterapia , Obesidad/patología , Obesidad/fisiopatología , Sobrepeso/patología , Sobrepeso/fisiopatología , Taiwán , Té/efectos adversos , Circunferencia de la Cintura , Pérdida de Peso , Adulto Joven
19.
J Med Food ; 14(10): 1135-43, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21895415

RESUMEN

Chronic hepatitis/cirrhosis is the eighth leading cause of death in Taiwan. Excess accumulated extracellular matrix produced by activated hepatic stellate cells (HSCs) is the major cause of liver fibrosis. Ginsenoside Rb1, the most active compound purified from ginseng, has been considered to be hepatoprotective. This study investigated the effects of ginsenoside Rb1 (98.8% purity) on activation, proliferation, and profibrotic factors in rat HSC-T6 cells under H2O2 oxidative stress. Rat HSC-T6 cells were activated by 10 nM H2O2 and then incubated with different concentrations of ginsenoside Rb1 (5, 10, 20, 40, and 80 µg/mL) for 24 hours. Medium containing 0.08% dimethyl sulfoxide or 5 mM N-acetyl-l-cysteine was used as a negative or positive control, respectively. The results showed that ginsenoside Rb1 at 5-40 µg/mL significantly reduced α-smooth muscle actin levels and at 5-80 µg/mL inhibited cell proliferation in HSC-T6 cells after induction with H2O2 (P<.05). Collagen secreted by HSC-T6 cells was decreased by ginsenoside Rb1 at 5-80 µg/mL (P<.05). Protein expression of transforming growth factor-ß1 (TGF-ß1), matrix metalloproteinase (MMP)-2, and tissue inhibitor of metalloproteinase (TIMP)-1 was suppressed by ginsenoside Rb1 at 10-80 µg/mL (P<.05). In addition, mRNA expression of type I and III collagen, TGF-ß1, and TIMP-1 was inhibited by ginsenoside Rb1 (10 and 80 µg/mL) (P<.05). Therefore, ginsenoside Rb1 exerted an antifibrotic effect on HSCs by inhibiting activation, proliferation, and expression of collagen, TGF-ß1, MMP-2, and TIMP-1.


Asunto(s)
Ginsenósidos/farmacología , Células Estrelladas Hepáticas/citología , Células Estrelladas Hepáticas/efectos de los fármacos , Acetilcisteína/metabolismo , Animales , Línea Celular , Proliferación Celular/efectos de los fármacos , Supervivencia Celular , Colágeno/metabolismo , Dimetilsulfóxido/metabolismo , Peróxido de Hidrógeno/metabolismo , Cirrosis Hepática/tratamiento farmacológico , Cirrosis Hepática/patología , Metaloproteinasa 2 de la Matriz/genética , Metaloproteinasa 2 de la Matriz/metabolismo , Estrés Oxidativo/efectos de los fármacos , Ratas , Taiwán , Inhibidor Tisular de Metaloproteinasa-1/genética , Inhibidor Tisular de Metaloproteinasa-1/metabolismo , Factor de Crecimiento Transformador beta1/genética , Factor de Crecimiento Transformador beta1/metabolismo
20.
Nutrition ; 27(10): 1034-9, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21353475

RESUMEN

OBJECTIVE: The purpose of this study was to investigate the protective effects of combined treatment of folate and vitamin B12 against alcoholic liver disease. METHODS: Male Wistar rats weighing about 160 g were divided into four groups: an ethanol group fed an ethanol liquid diet; a control group pair-fed an isoenergetic diet without ethanol; an ethanol and vitamin group fed an ethanol-containing diet that was supplemented with folate (10 mg/kg of body weight per day) and vitamin B12 (0.5 mg/kg of body weight per day); and a control and vitamin group fed an isoenergetic diet without ethanol, which was supplemented with folate (10 mg/kg of body weight per day) and vitamin B12 (0.5 mg/kg of body weight per day). RESULTS: After 16 wk, the plasma folate concentration in the ethanol group was significantly lower than in the other three groups. The plasma homocysteine concentration in the ethanol group was significantly higher than in the other three groups. The hepatic matrix metalloproteinase-2 concentration in the ethanol group was significantly higher than in the control and ethanol/vitamin groups. Furthermore, the plasma homocysteine concentration at the 16th week and the hepatic matrix metalloproteinase-2 concentration showed a significant positive correlation in rats of each group. In addition, pathologic evidence of liver fibrosis was observed only in the ethanol group. Furthermore, hepatic cytochrome 2E1 protein expression in group E increased significantly. CONCLUSION: These results suggest that combined treatment of folate and vitamin B12 can alleviate alcoholic liver injury that may be related to normalization of plasma homocysteine levels.


Asunto(s)
Ácido Fólico/uso terapéutico , Homocisteína/sangre , Hiperhomocisteinemia/tratamiento farmacológico , Cirrosis Hepática Alcohólica/tratamiento farmacológico , Hígado/efectos de los fármacos , Vitamina B 12/uso terapéutico , Complejo Vitamínico B/uso terapéutico , Animales , Citocromos/metabolismo , Ácido Fólico/sangre , Ácido Fólico/farmacología , Hiperhomocisteinemia/metabolismo , Hiperhomocisteinemia/patología , Hígado/metabolismo , Hígado/patología , Cirrosis Hepática Alcohólica/patología , Pruebas de Función Hepática , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Ratas , Ratas Wistar , Vitamina B 12/farmacología , Complejo Vitamínico B/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA